Categories: News

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.


On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, May 8, 2024. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Jim Mazzola

Investor Relations

jmazzola@outsetmedical.com

Staff

Recent Posts

Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway

Calgary, Alberta--(Newsfile Corp. - November 25, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:…

18 seconds ago

Maverick Medical AI, NewVue.ai, and RADPAIR Announce Strategic Integration to Reduce Burnout and Optimize Financial Performance

Real-Time Revenue Cycle Management and Clinical Workflow Optimization for Radiology Practices to Debut at RSNA…

2 hours ago

Cortechs.ai Partners with Mermaid Beach Radiology to Bring Precision AI Imaging Solutions to Their MRI and CT Services

SAN DIEGO, Nov. 25, 2024 /PRNewswire/ -- Cortechs.ai, a leading provider of AI-powered imaging solutions,…

2 hours ago

Chicago Tribune Names American Association of Nurse Anesthesiology a Winner of its Top Workplaces 2024 Award

ROSEMONT, Ill., Nov. 25, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) has…

2 hours ago

At AAEP 2024, Agfa showcases SmartRotate™ for Equine, powered by artificial intelligence

Specialized for veterinary care, SmartRotate™ for Equine automatically presents each image in the correct orientation,…

2 hours ago

Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with ‘Neurophet AQUA’

New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy…

2 hours ago